{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:52:59Z","timestamp":1790855579609,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.lfs.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T02:46:31Z","timestamp":1432694791000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The role of leptin in the pathophysiology of rheumatoid arthritis"],"prefix":"10.1016","volume":"140","author":[{"given":"\u00c9ric","family":"Toussirot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Binda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2015.05.001_bb0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/092986707780362826","article-title":"The contribution of adipose tissue and adipokines to inflammation in joint diseases","volume":"14","author":"Toussirot","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2015.05.001_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00394-012-0370-0","article-title":"The role of adipokines in connective tissue diseases","volume":"51","author":"Krysiak","year":"2012","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/157339508784325046","article-title":"Leptin and inflammation","volume":"4","author":"Iikuni","year":"2008","journal-title":"Curr. Immunol. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2015.05.001_bb0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/rheumatology\/kel157","article-title":"Towards a pro-inflammatory and immunomodulatory emerging role of leptin","volume":"45","author":"Otero","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/cei.12372","article-title":"Emerging role of leptin in rheumatoid arthritis","volume":"177","author":"Tian","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2015.05.001_bb0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fimmu.2014.00576","article-title":"Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)","volume":"5","author":"Gremese","year":"2014","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2015.05.001_bb0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2015.05.001_bb0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jbspin.2014.01.009","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"81","author":"Soubrier","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"6505","key":"10.1016\/j.lfs.2015.05.001_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1073\/pnas.94.3.1023","article-title":"Role of leptin in hypothalamic\u2013pituitary function","volume":"94","author":"Yu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.febslet.2004.11.024","article-title":"Leptin, from fat to inflammation: old questions and new insights","volume":"579","author":"Otero","year":"2005","journal-title":"FEBS Lett."},{"issue":"1 Pt 2","key":"10.1016\/j.lfs.2015.05.001_bb0065","first-page":"R204","article-title":"IL-1 beta mediates leptin induction during inflammation","volume":"274","author":"Faggioni","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-291X(02)02838-3","article-title":"Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines","volume":"300","author":"Zhao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6696","key":"10.1016\/j.lfs.2015.05.001_bb0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jc.2005-1220","article-title":"Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy","volume":"91","author":"Oral","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.lfs.2015.05.001_bb0085","doi-asserted-by":"crossref","first-page":"e26586","DOI":"10.4161\/onci.26586","article-title":"The interplay between regulatory T cells and metabolism in immune regulation","volume":"2","author":"Zeng","year":"2013","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","article-title":"A key role of leptin in the control of regulatory T cell proliferation","volume":"26","author":"De Rosa","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/oby.20087","article-title":"Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk","volume":"21","author":"Wagner","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molmed.2010.04.002","article-title":"Regulatory T cells in obesity: the leptin connection","volume":"16","author":"Matarese","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ijo.2008.216","article-title":"Increased activity of interleukin-23\/interleukin-17 proinflammatory axis in obese women","volume":"33","author":"Sumarac-Dumanovic","year":"2009","journal-title":"Int. J. Obes."},{"issue":"5","key":"10.1016\/j.lfs.2015.05.001_bb0110","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2009.111732","article-title":"Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis","volume":"69","author":"Xibill\u00e9-Friedmann","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0115","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar3774","article-title":"Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?","volume":"14","author":"Paquet","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0120","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4049\/jimmunol.168.2.875","article-title":"Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis","volume":"168","author":"Busso","year":"2002","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2015.05.001_bb0125","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.peptides.2011.06.015","article-title":"Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis","volume":"32","author":"Otvos","year":"2011","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.lfs.2015.05.001_bb0130","first-page":"707","article-title":"Acquired leptin resistance by high-fat feeding reduces inflammation from collagen antibody-induced arthritis in mice","volume":"30","author":"Sugioka","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.lfs.2015.05.001_bb0135","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/art.34637","article-title":"Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response","volume":"64","author":"Deng","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/ar332","article-title":"Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration","volume":"3","author":"Hultgren","year":"2001","journal-title":"Arthritis Res."},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0145","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.62.10.913","article-title":"A role for leptin in rheumatic diseases?","volume":"62","author":"Palmer","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0150","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.62.10.952","article-title":"Leptin consumption in the inflamed joints of patients with rheumatoid arthritis","volume":"62","author":"Bokarewa","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/keh421","article-title":"Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis","volume":"44","author":"Toussirot","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0160","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/ard.2005.046540","article-title":"Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis","volume":"65","author":"Otero","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0165","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.smj.0000240625.27772.79","article-title":"Serum leptin levels in rheumatoid arthritis and relationship with disease activity","volume":"99","author":"Gunaydin","year":"2006","journal-title":"South. Med. J."},{"issue":"7","key":"10.1016\/j.lfs.2015.05.001_bb0170","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00296-008-0764-8","article-title":"Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis","volume":"29","author":"Seven","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0175","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00296-010-1698-5","article-title":"Synovial\/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion","volume":"32","author":"Olama","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.lfs.2015.05.001_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2169\/internalmedicine.50.4306","article-title":"Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis","volume":"50","author":"Yoshino","year":"2011","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0185","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0026-0495(99)90174-9","article-title":"Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis","volume":"48","author":"Anders","year":"1999","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.lfs.2015.05.001_bb0190","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/ard.2004.032243","article-title":"Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis","volume":"64","author":"Popa","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2015.05.001_bb0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-006-0264-7","article-title":"Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis?","volume":"27","author":"Hizmetli","year":"2007","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.lfs.2015.05.001_bb0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fimmu.2013.00453","article-title":"Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study","volume":"4","author":"Toussirot","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/annrheumdis-2011-200123","article-title":"Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network","volume":"71","author":"Kontny","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00296-006-0253-x","article-title":"Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis","volume":"27","author":"Lee","year":"2007","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0215","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00296-007-0480-9","article-title":"Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity","volume":"28","author":"Targo\u0144ska-Stepniak","year":"2008","journal-title":"Rheumatol. Int."},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0220","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00296-007-0335-4","article-title":"Serum leptin in rheumatoid arthritis","volume":"27","author":"Wis\u0142owska","year":"2007","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0225","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00296-009-1053-x","article-title":"Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis","volume":"30","author":"Targo\u0144ska-Stepniak","year":"2010","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.lfs.2015.05.001_bb0230","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/ard.2003.011619","article-title":"Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"63","author":"H\u00e4rle","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2015.05.001_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11845-014-1072-9","article-title":"Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis","volume":"183","author":"Tian","year":"2014","journal-title":"Ir. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2015.05.001_bb0240","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.24626","article-title":"Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis","volume":"60","author":"Rho","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0245","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.24789","article-title":"Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis","volume":"61","author":"Giles","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0250","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/ard.2011.150813","article-title":"Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis","volume":"70","author":"Giles","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0255","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/art.30449","article-title":"Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis","volume":"63","author":"Klein-Wieringa","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0260","doi-asserted-by":"crossref","first-page":"R210","DOI":"10.1186\/ar4404","article-title":"Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort","volume":"15","author":"Meyer","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/mmr.2013.1764","article-title":"Serum adipokine levels in rheumatoid arthritis patients and their contributions to the resistance to treatment","volume":"9","author":"Kim","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2015.05.001_bb0270","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/ar3169","article-title":"Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin : a randomized study over 21months","volume":"12","author":"Engvall","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2015.05.001_bb0275","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3899\/jrheum.080626","article-title":"Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis","volume":"36","author":"Popa","year":"2009","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.lfs.2015.05.001_bb0280","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2005.040857","article-title":"No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis","volume":"65","author":"H\u00e4rle","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0285","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1152\/ajpendo.00089.2007","article-title":"Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome","volume":"293","author":"Lo","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0290","first-page":"222","article-title":"Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis","volume":"27","author":"Gonzalez-Gay","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.lfs.2015.05.001_bb0295","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1136\/ard.2011.152603","article-title":"Adipokine profile is modulated in subcutaneous adipose tissue by TNF\u03b1 inhibitors in patients with rheumatoid arthritis","volume":"70","author":"\u0160enolt","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0300","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/annrheumdis-2011-200646","article-title":"Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis","volume":"71","author":"Klaasen","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0305","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00394-013-0599-2","article-title":"TNF\u03b1 blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study","volume":"53","author":"Toussirot","year":"2014","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.30136","article-title":"Body mass index and clinical response to infliximab in rheumatoid arthritis","volume":"63","author":"Klaasen","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0315","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/acr.21768","article-title":"Obesity and reduction of the response rate to anti-tumor necrosis factor \u03b1 in rheumatoid arthritis: an approach to a personalized medicine","volume":"65","author":"Gremese","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"8","key":"10.1016\/j.lfs.2015.05.001_bb0320","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/acr.21978","article-title":"Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients","volume":"65","author":"Heimans","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"11","key":"10.1016\/j.lfs.2015.05.001_bb0325","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2013-205094","article-title":"Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis","volume":"73","author":"Sandberg","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0330","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.lfs.2015.05.001_bb0335","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.lfs.2015.05.001_bb0340","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis","volume":"78","author":"Boyer","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/j.lfs.2015.05.001_bb0350","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rinc\u00f3n","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"24","key":"10.1016\/j.lfs.2015.05.001_bb0355","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3132\/dvdr.2005.018","article-title":"Inflammation, thrombosis and acute coronary syndromes","volume":"2","author":"Carter","year":"2005","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"16","key":"10.1016\/j.lfs.2015.05.001_bb0365","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0370","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2015.05.001_bb0375","first-page":"w13211","article-title":"Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis","volume":"141","author":"Ferraccioli","year":"2011","journal-title":"Swiss Med. Wkly."},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0380","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/rheumatology\/keh321","article-title":"Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions","volume":"43","author":"Rall","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0385","first-page":"1505","article-title":"Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor","volume":"19","author":"Roubenoff","year":"1992","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0390","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/keq266","article-title":"Obesity in rheumatoid arthritis","volume":"50","author":"Stavropoulos-Kalinoglou","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.lfs.2015.05.001_bb0395","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/rheumatology\/36.4.444","article-title":"Body composition in rheumatoid arthritis","volume":"36","author":"Westhovens","year":"1997","journal-title":"Br. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0400","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.23719","article-title":"Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies","volume":"59","author":"Giles","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.lfs.2015.05.001_bb0405","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/ker004","article-title":"Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis","volume":"50","author":"Dao","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.lfs.2015.05.001_bb0410","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: an update","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0415","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ. Res."},{"issue":"6428","key":"10.1016\/j.lfs.2015.05.001_bb0420","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","article-title":"Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13year follow up of participants in the study of men born in 1913","volume":"288","author":"Larsson","year":"1984","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.lfs.2015.05.001_bb0425","doi-asserted-by":"crossref","first-page":"343746","DOI":"10.1155\/2014\/343746","article-title":"Adipokines, metabolic syndrome and rheumatic diseases","volume":"2014","author":"Abella","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.lfs.2015.05.001_bb0430","first-page":"3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Phase III) final report","volume":"106","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0435","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3899\/jrheum.100346","article-title":"Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease","volume":"38","author":"Crowson","year":"2011","journal-title":"J. Rheumatol."},{"issue":"14","key":"10.1016\/j.lfs.2015.05.001_bb0440","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0445","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/ar4412","article-title":"Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis","volume":"15","author":"Dessein","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.lfs.2015.05.001_bb0450","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.23766","article-title":"Association of body fat with C-reactive protein in rheumatoid arthritis","volume":"58","author":"Giles","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"25","key":"10.1016\/j.lfs.2015.05.001_bb0455","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","article-title":"Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)","volume":"104","author":"Wallace","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2015.05.001_bb0460","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11906-008-0025-y","article-title":"Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease","volume":"10","author":"Patel","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2015.05.001_bb0465","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar4384","article-title":"Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis","volume":"15","author":"Kang","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2015.05.001_bb0470","first-page":"461849","article-title":"Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk","volume":"2013","author":"Dessein","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.lfs.2015.05.001_bb0475","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00296-013-2933-7","article-title":"Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study","volume":"34","author":"Dessein","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.lfs.2015.05.001_bb0480","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.27376","article-title":"Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis","volume":"62","author":"Rho","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.lfs.2015.05.001_bb0485","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s100670050125","article-title":"Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation","volume":"18","author":"Fraser","year":"1999","journal-title":"Clin. Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.05.001_bb0490","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jim.2006.03.011","article-title":"Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation","volume":"312","author":"Fazeli","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.lfs.2015.05.001_bb0495","doi-asserted-by":"crossref","first-page":"568343","DOI":"10.1155\/2010\/568343","article-title":"Role of leptin in the activation of immune cells","volume":"2010","author":"Fern\u00e1ndez-Riejos","year":"2010","journal-title":"Mediat. Inflamm."},{"issue":"12","key":"10.1016\/j.lfs.2015.05.001_bb0500","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/ard.2007.069377","article-title":"Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention","volume":"66","author":"Iliopoulos","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2015.05.001_bb0505","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14728222.10.1.135","article-title":"Shp2 as a therapeutic target for leptin resistance and obesity","volume":"10","author":"Feng","year":"2006","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051500257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051500257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T07:11:53Z","timestamp":1617606713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051500257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":101,"alternative-id":["S002432051500257X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.05.001","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of leptin in the pathophysiology of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}